| General Kansas Telemedicine Llc | |
|
852 Minnesota Ave Kansas City KS 66101-2609 | |
| (913) 549-4184 | |
| Not Available |
| Full Name | General Kansas Telemedicine Llc |
|---|---|
| Speciality | Family Medicine |
| Location | 852 Minnesota Ave, Kansas City, Kansas |
| Authorized Official Name and Position | Jose Flores (DIRECTOR) |
| Authorized Official Contact | 8325389188 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| General Kansas Telemedicine Llc 852 Minnesota Ave Kansas City KS 66101-2609 Ph: (913) 549-4184 | General Kansas Telemedicine Llc 852 Minnesota Ave Kansas City KS 66101-2609 Ph: (913) 549-4184 |
| NPI Number | 1154041788 |
|---|---|
| Provider Enumeration Date | 09/01/2022 |
| Last Update Date | 09/01/2022 |
| Medicare PECOS PAC ID | 6608243555 |
|---|---|
| Medicare Enrollment ID | O20221104001957 |
News Archive
New research appears to settle the on-going debate over whether the culprit in the current obesity epidemic is a lack of exercise or too much food.
Allos Therapeutics, Inc. (Nasdaq:ALTH) today announced that last night the U.S. Food and Drug Administration (FDA) granted accelerated approval for FOLOTYNTM (pralatrexate injection) for use as a single agent for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma (PTCL).
Private radiology practices have been especially hard hit by the COVID-19 pandemic, and the steps they take to mitigate the impact of the pandemic on their practice will shape the future of radiology, according to a special report from the Radiological Society of North America COVID-19 Task Force, published today in the journal Radiology.
RegeneRx Biopharmaceuticals, Inc. announced that it has received Orphan Drug designation from U.S. FDA's Office of Orphan Products Development for its drug candidate, Thymosin beta 4 (Tβ4), for the treatment of Neurotrophic Keratopathy, a serious degenerative disease of the corneal epithelium (the outside layer of the eye).
› Verified 9 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1154041788 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | (* (Not Available)) | Primary |
| Provider Name | Victoria Forsberg |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1255831210 PECOS PAC ID: 9830452242 Enrollment ID: I20221104002023 |
News Archive
New research appears to settle the on-going debate over whether the culprit in the current obesity epidemic is a lack of exercise or too much food.
Allos Therapeutics, Inc. (Nasdaq:ALTH) today announced that last night the U.S. Food and Drug Administration (FDA) granted accelerated approval for FOLOTYNTM (pralatrexate injection) for use as a single agent for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma (PTCL).
Private radiology practices have been especially hard hit by the COVID-19 pandemic, and the steps they take to mitigate the impact of the pandemic on their practice will shape the future of radiology, according to a special report from the Radiological Society of North America COVID-19 Task Force, published today in the journal Radiology.
RegeneRx Biopharmaceuticals, Inc. announced that it has received Orphan Drug designation from U.S. FDA's Office of Orphan Products Development for its drug candidate, Thymosin beta 4 (Tβ4), for the treatment of Neurotrophic Keratopathy, a serious degenerative disease of the corneal epithelium (the outside layer of the eye).
› Verified 9 days ago
News Archive
New research appears to settle the on-going debate over whether the culprit in the current obesity epidemic is a lack of exercise or too much food.
Allos Therapeutics, Inc. (Nasdaq:ALTH) today announced that last night the U.S. Food and Drug Administration (FDA) granted accelerated approval for FOLOTYNTM (pralatrexate injection) for use as a single agent for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma (PTCL).
Private radiology practices have been especially hard hit by the COVID-19 pandemic, and the steps they take to mitigate the impact of the pandemic on their practice will shape the future of radiology, according to a special report from the Radiological Society of North America COVID-19 Task Force, published today in the journal Radiology.
RegeneRx Biopharmaceuticals, Inc. announced that it has received Orphan Drug designation from U.S. FDA's Office of Orphan Products Development for its drug candidate, Thymosin beta 4 (Tβ4), for the treatment of Neurotrophic Keratopathy, a serious degenerative disease of the corneal epithelium (the outside layer of the eye).
› Verified 9 days ago
Swope Health Services Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 4835 State Ave, Kansas City, KS 66102 Phone: 913-321-2200 | |
Creative Health Care Management Llc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 2300 N 113th Ter, Kansas City, KS 66109 Phone: 317-204-3736 Fax: 317-449-5783 | |
Ku Health Partners, Inc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 3901 Rainbow Blvd # Ms 3707, Kansas City, KS 66160 Phone: 913-588-5277 Fax: 913-588-1693 | |
Professional Services Of Ku Hospital Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 4810 State Ave, Professional Services Of Ku Hospital, Kansas City, KS 66102 Phone: 913-321-4567 Fax: 913-321-6789 | |
Access Health & Injury Solutions, Inc. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 9535 State Ave, Kansas City, KS 66111 Phone: 913-299-0911 Fax: 913-788-9679 | |
Centerwell Senior Primary Care- State Avenue Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 7527 State Ave, Kansas City, KS 66112 Phone: 913-335-6986 Fax: 855-446-7151 | |
Alanna Lee Md An Operating Division Of Providence Medical Center Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 2040 Hutton Rd, Suite 102, Kansas City, KS 66109 Phone: 913-299-3700 Fax: 913-299-3050 |